The promoters of Aster DM Healthcare have increased their shareholding by 4% from 37.88% to 41.88%, after acquiring additional stake from one of the large private equity investors at an additional investment of Rs 460 crore.

Aster DM Healthcare, with a turnover of Rs 10,253 crore in FY 2021-22, is performing well during this FY in turnover and profits with a stage of growth, due to restructuring of India and Gulf Cooperation Council (GCC) businesses being pursued actively.

In India, the company is moving ahead with new projects like 350-bedded Aster Capital Hospital in Trivandrum - Kerala, 200 bedded Aster MIMS Hospital in Kasargod - Kerala, 150-bedded Aster Narayanadri Hospital in Tirupati – Andhra Pradesh, 100-bedded Aster G Madegowda Hospital in Mandya – Karnataka among others.

It has also rolled out 239 Aster pharmacies and 177 Aster Labs & patient experience centres already. With 4,095 beds in 15 hospitals in India going up to 4,670 in 18 hospitals next financial year, Aster shall be connecting all the above through the myAster App that is going to be launched this year to give omni channel care to the customers. 

The launch of 181 bed Aster Royal Hospital in Oman, 101 bed Aster Hospital in Sharjah and the acquisition of a 126 bedded hospital in Al Qusais which would be operational soon, will make Aster one of the largest healthcare providers in GCC with 15 hospitals, 113 clinics and 257 pharmacies. The company has embarked on a plan to roll out 250 new Aster Pharmacies in the Kingdom of Saudi Arabia.  The Omni channel healthcare delivery is being tied up with the myAster App which has already received 352,000+ downloads within a short period since its launch.